MedPath

The effect of L-glutamine on oral mucositis induced by chemoradiotherapy in patients with head and neck cancer.

Not Applicable
Conditions
Head and neck cancer.
Registration Number
JPRN-UMIN000024045
Lead Sponsor
Shiga University of Medical Science Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1)Unable intake glutamine formulations per oral or per enteral tube. 2)major impairment of liver 3)major impairment of kidney 4)allergic to L-glutamine 5)pregnant,lactating 6)presence of other cancer under treatment. 7)severe psychosis or psychiatric symptoms 8)paticipation judged by physician to be inadvisable 9)paticipation not taking opioids

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
CTCAE score for inflammation of oral pharyngeal mucosa.
Secondary Outcome Measures
NameTimeMethod
1)Physical measurement Body weight, Lean body weight, body fat mass, Grip strength 2)Digestive symptom oral mucositis, taste disturbance, diarrhea, appetite 3)score of Quality of life(QOL) EORT-QLQ-C30 4)Blood test Alb,TP,PA,RBP,serum diamine oxidase activity,IL-6,active ghrelin 5)Amount of total Energy by oral feeding, enteral feeding, parenteral nutrition 6)Duration and dosage of opioid. 7)Rate of CRT completion.
© Copyright 2025. All Rights Reserved by MedPath